IMmune Proteomics to Predict neoAdjuvant Chemotherapy and immunoTherapy Response in Gastric Cancer

Clinical trial NCT06662110 · RECRUITING

Trial details

NCT number: NCT06662110
Sponsor: Shanghai Zhongshan Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Gastric Cancer, Gastroesophageal Junction Cancer

Start date: 2024-08-01
Primary completion: 2026-06-30
Enrollment: 206

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.